D. Medical completes sale of NextGen Biomed
D. Medical Industries (NASDAQ, TASE:DMED) has closed the sale of its holdings in its publicly held subsidiary, NextGen Biomed, for $1.6 million. D. Medical is a medical device company engaged through...
View ArticleD. Medical gets first payment under worldwide OEM pact
D. Medical Industries (NASDAQ, TASE:DMED) has received the first payment under an original equipment manufacturer agreement with Twobiens Ltd., a leading South Korea-based supplier of diabetes...
View ArticleDURECT awaiting Pfizer meeting with FDA on Remoxy
DURECT (NASDAQ:DRRX) has a lot riding on a meeting in late March between its marketing partner, Pfizer, and the FDA to discuss resubmitting a new drug application for its lead pain drug, Remoxy, as a...
View Article
More Pages to Explore .....